Psicodelix
en
en
en
en
en
en
Date of Foundation
2024

Psicodelix

"Psicodelix: Bridging tech and nature for enhanced mental wellness."

Contact

The Idea origin story

Psicodelix is a pioneer in digital health, combining nature and advanced technology for mental well-being. The platform caters to the increasing demand for holistic wellness solutions by offering evidence-based psilocybin microdosing regimens. Addressing gaps in traditional mental health treatments, Psicodelix provides an integrated approach that merges different disciplines for optimal results. The company also gathers patient data showing significant improvements in various metrics related to mental health.

The Mission

"Revolutionizing mental health treatment through neural modulation and consciousness expansion to target the root cause, not just symptoms."

Clients

"Our customers are adults with persistent mental health issues seeking effective, science-based alternatives to conventional treatments."

Problems we solve

Client’s problem

Your startup could potentially provide an effective and sustainable solution to severe mental health conditions where conventional treatments fall short, by using a holistic approach to address both symptoms and root causes.

Confirmation of problem

mental health issues are on the rise and conventional treatments often fall short or entail side effects.

Solution

Psicodelix provides psilocybin microdosing through online treatment protocols and digital research and data generation

Our technologies

This solution is based on technologies

Telemedicine platform, AI/ML for personalization of treatment, blockchain for data security & privacy.

How it works

Psicodelix blends scientific research and technology to offer safe, user-friendly psilocybin microdosing for holistic wellness.

Value for the client

Our product's efficacy is measured using rigorous metrics and patient feedback, reducing reliance on conventional medications.

Market and strategy

Market size

72000

mln/year

We estimate the market size for which our solution is designed in monetary terms as follows

Market share goal

1

% of the market

Is our goal in the next 3 years

Team

My name’s

Duda Gouvêa Vieira

My key role in the product

My key role is venture builder and investor, responsible for identifying potential startups, providing funding, aiding in strategic planning and growth.

Team size and key members

so far one man show.

Competitors

Competitors

In the wellness industry, other mental health apps and alternative therapy platforms can be seen as competitors. Traditional pharmaceutical companies offering mental health solutions are also potential competition.

Our Advantages

Leveraging the growing acceptance of psilocybin therapy, Psicodelix is primed for rapid growth. With an existing operational base and a committed ESG approach, it stands ready to tackle humanity's major challenges post-Covid.

Business model

selling psilocybin-based products and therapy protocols

Traction

Product progress is on an upward trend with accelerating revenue growth. Our digital platform continually advances, enhancing functionality and value.

Company's growth potential amplified by 400%, showcasing unprecedented progress and capacity escalation.

Metrics

Primary KPI is mental health scale improvement. Growth strategies include therapist training platform and a welcoming team for new leads. Existing protocols and system automation offer medium impact, minor updates yield straightforward improvements.

The company's EBITDA is virtually at zero, maintaining consistent monthly yields of approximately $10k. This shows operational efficiency despite minimal earnings before interest, taxes, depreciation and amortization.

Incorporation

Our company incorporated in

Brazil for now

Key risks

Regulation changes affecting psilocybin, potential adverse health reactions, scalability and adoption hurdles in promoting an unconventional therapy, securing continuous funding for research and development.

Investments

$

it is a bootstrap, I am planning to invest with a group of friends

We raised investments

Our Investors

currently company´s cap table is clean.

Rising Investments

$

100k

Currently, we are raising investments

$

2M

Estimated pre-investment valuation of the company

Request additional information

We’re looking for a co-founders

Open positions

Article

Read

Additional information

Psicodelix
Growth
Date of Foundation
2024